Technical Analysis for IGCC - India Globalization Capital Inc.

Grade Last Price % Change Price Change
grade A 2.76 44.50% 0.8500
IGCC closed up 44.5 percent on Monday, February 25, 2019, on 15.57 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical IGCC trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New Uptrend Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%

Older signals for IGCC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.
Medicine Cancer Medicinal Plants Clinical Medicine Health Sciences Cannabis Smoking Herbalism Medical Cannabis Steel Pain Effects Of Cannabis Disorders Antiemetics Epilepsy Alzheimer's Antioxidants Central Nervous System Disorders Nausea Vomiting Parkinson's Aids Central Nervous System Disease Seizures
Is IGCC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 3.3
52 Week Low 0.25
Average Volume 938,864
200-Day Moving Average 0.0
50-Day Moving Average 0.4893
20-Day Moving Average 0.5783
10-Day Moving Average 0.7695
Average True Range 0.301
ADX 27.32
+DI 69.0573
-DI 1.8209
Chandelier Exit (Long, 3 ATRs ) 2.397
Chandelier Exit (Short, 3 ATRs ) 1.219
Upper Bollinger Band 1.7805
Lower Bollinger Band -0.6239
Percent B (%b) 1.41
BandWidth 415.770361
MACD Line 0.2702
MACD Signal Line 0.0577
MACD Histogram 0.2125
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.8200
Resistance 3 (R3) 5.6600 4.4800 5.3100
Resistance 2 (R2) 4.4800 3.7007 4.5600 5.1399
Resistance 1 (R1) 3.6200 3.2193 4.0500 3.7800 4.9699
Pivot Point 2.4400 2.4400 2.6550 2.5200 2.4400
Support 1 (S1) 1.5800 1.6607 2.0100 1.7400 0.5501
Support 2 (S2) 0.4000 1.1793 0.4800 0.3801
Support 3 (S3) -0.4600 0.4000 0.2100
Support 4 (S4) -0.3000